A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region

Seasonal influenza represents a huge health burden, resulting in significant mortality and morbidity.

Following the 2009 H1N1 pandemic, focus has been directed on the burden of influenza globally.

Country and regional disease burden estimates play important roles in helping inform decisions on national influenza intervention programmes.

Despite improvements in influenza surveillance following the 2009 pandemic, many opportunities remain unexplored in the Eastern Mediterranean and North African (EMNA) region, which has a high prevalence of patients with chronic disease and thus a population at high risk of influenza complications.

We conducted a systematic literature review of Embase, Medline, Scopus and the Cochrane Database of Systematic Reviews from 1 January 1998 to 31 January 2020 covering the EMNA region with the aim to describe the epidemiology of influenza in the region and assess the influenza epidemiological surveillance research landscape.

Relevant data on study characteristics, population, clinical/virology characteristics and epidemiology were extracted and summarised descriptively.

Of the 112 studies identified for inclusion, 90 were conducted in the Eastern Mediterranean region, 19 in North Africa and three across the EMNA region.

Data were reported on 314,058 laboratory-confirmed influenza cases, 96 of which were derived from surveillance systems.

Amongst the surveillance studies, the percentage of positive cases reported ranged from 1% to 100%.

The predominantly identified influenza strain was strain A; H1N1 was the most prominent circulating subtype.

Typing was performed in approximately 75% and subtyping in 50% of studies, respectively.

Data on those considered most at risk for influenza complications were collected in 21% of studies, highlighting a regional gap for these data.

Our review reveals existing gaps in regional estimates of influenza health and economic burden, hospitalisation rates and duration, and highlights the need for robust and high-quality epidemiology data to help inform public health interventions.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-021-00534-3.